Figure 1 | Expression of miR-34 is correlated with p53 status in MEFs. a, An unsupervised hierarchical clustering based on miRNA expression profiles in wild-type and p53 2/2 MEFs with the indicated additional genetic alteration. Two independently constructed cell lines (.1 and .2) were analysed in each case. The complete heat map (linear scale) is presented in Supplementary  Fig. S1 . b, Predicted gene structures for human mir-34a and mir-34b/c were generated by combining information from expressed sequence tag databases, CAGE databases and 59 rapid amplification of cDNA ends. Sequence conservation between human, mouse and rat are represented as the percentage of conservation in the Vista analysis shown in the lower panel. The promoter regions of mir-34a and mir-34b/c each contain a palindromic sequence (shown in blue) that matches the canonical p53 binding site. The green bar indicates a CpG island. kb, kilobase. miR-34s belong to an evolutionarily conserved miRNA family, with single, recognizable orthologues in several invertebrate species ( Supplementary Fig. S2 ). According to predicted gene structures, human miR-34a is located within exon 2 of its primary transcript, whereas miR-34b and miR-34c are located within intron 1 and exon 2, respectively, of the same primary transcript (Fig. 1b) . Aside from the miRNAs themselves, the only other region of significant sequence conservation in mir-34 genes lies in their putative promoter regions (Fig. 1b) .
Because expression of miR-34s was correlated with p53 status, we asked whether miR-34s were directly regulated by p53. In MEFs expressing a tetracycline-regulated p53 short hairpin RNA (shRNA), endogenous p53 activity gradually increased over 6-8 days after repression of the shRNA 6 . Reactivation of p53 led to significant induction of both primary (pri-) mir-34 transcripts and mature miR-34s (Fig. 2a, and Supplementary Fig. S3A ). The kinetics and magnitude of induction were comparable to those of the canonical p53 target, p21 ( Supplementary Fig. S3A ). Silencing of p53 in human tumour cell lines led to a roughly fourfold decrease in miR-34a levels ( Supplementary Fig. S3B ).
Multiple physiological stresses can induce the accumulation of p53 protein and activate p53-mediated transcriptional programmes. DNA damage mediates p53 activation mainly through posttranslational modification 10, 11 . In a p53-dependent manner, both pri-mir-34s and mature miR-34s were induced by ionizing radiation in a variety of mouse tissues, including spleen, colon, thymus and kidney (Fig. 2b, Supplementary Fig. S4A , and data not shown). miR34s were also induced after DNA damage in wild-type but not p53-null MEFs, with an amplitude and kinetics that closely resembled those of p21 ( Supplementary Fig. S4B, C) . Similarly, in TOV21G levels were measured in MEFs expressing a tetracycline-repressible p53 shRNA 6 at the indicated times after the addition of doxycycline. White columns, mature miR-34a; grey columns, mature miR-34b; black columns, mature miR-34c. b, Wild-type and p53 2/2 animals were subjected to 6 Gy of ionizing radiation (IR), and miR-34 levels (identified as in a) were measured in spleens by Taqman assays both before and at the indicated times after irradiation. Unt., unirradiated. c, A group of 191 miRNAs and selected miRNA* sequences were quantified by QRT-PCR in TOV21G cells before and after treatment with 0.1 mg ml 21 adriamycin (Adr.). Results are presented in a logarithmic-scale dot plot of copy number per cell. The full data set is presented in Supplementary Table S1 . d, Hepatocellular carcinomas were produced by combined expression of activated Ras and a conditional p53 shRNA 13 . p53 suppression was relieved by treatment with doxycycline (Dox.). Tumours were harvested at the indicated times during treatment with doxycycline, and levels of mature miR-34 were measured by Taqman assays. Levels are plotted with respect to tumours before p53 reactivation. Left: white columns, pri-mir-34a; grey columns, pri-mir-34b/ 34c; black columns, mp21. Right: column colours as in a. e, ChIPs were performed with p53 antibodies on wild-type MEFs (white columns) or p53 2/2 MEFs (black columns) treated with adriamycin. BS indicates quantification of the fragment containing the predicted p53 binding site in the mir-34a, mir-34b/c or p21 promoter regions, and Ctrl indicates a 39 fragment from the same gene. Signals were normalized to glyceraldehyde-3-phosphate dehydrogenase (GAPDH) for each genotype. f, Firefly luciferase coding sequences were placed under the transcriptional control of human mir-34a or mir-34b/c promoter elements containing either wild-type or mutant (as indicated) p53 binding sites. These reporters were co-transfected with either control (white columns) or human p53 expression plasmids (black columns). Transfections were normalized by using a simultaneously delivered Renilla luciferase expression plasmid, pRLTK. In all cases, error bars indicate s.d. (n 5 3).
cells, a human ovarian cancer cell line, members of the miR-34 family had one of the highest levels of induction after DNA damage among the miRNAs examined (Fig. 2c , and Supplementary Table S1 ).
Oncogene activation often induces the p53 pathway through induction of ARF (alternative reading frame) 12 . Such a response was evident in a mouse hepatocellular carcinoma model, in which tumorigenesis driven by activated Ras required continuous suppression of p53 by an inducible shRNA 13 . Repression of the shRNA allowed Ras-mediated activation of endogenous p53 and resulted in the senescence of tumour cells 13 . Under these circumstances, all three miR-34s were strongly induced, supporting their regulation by p53 in vivo (Fig. 2d) . Similarly, oncogenic stress can induce miR-34a in cultured primary human fibroblasts (data not shown).
One of the few conserved regions within the genes encoding miR-34 family members contains a match to the canonical p53 binding site (see Fig. 1b ). To test p53 binding to these sites, we performed chromatin immunoprecipitation (ChIP). In wild-type MEFs, in which p53 activity was induced by DNA damage, regions of the genes encoding both miR-34a and miR-34b/c that contained putative p53 binding sites were enriched in p53 immunoprecipitates. This enrichment was absent from similarly treated p53-null MEFs (Fig. 2e) . These same sites were previously detected in genome-wide chromatin occupancy experiments with p53, though their significance for regulation of miR-34s was not noted 14 . To examine the potential of mir-34 promoters to confer p53 regulation, we inserted fragments of the mouse or human genes encoding miR-34a or miR34b/c upstream of a luciferase-coding region. Co-transfection of these reporters with a p53 expression vector robustly stimulated luciferase expression (Fig. 2f , and data not shown). Mutation of p53 binding sites in these reporters negated this induction. These findings indicate that miR-34a and miR-34b/c are direct transcriptional targets of p53.
Two major endpoints of p53 activation are apoptosis and growth arrest (either cell cycle arrest or senescence). The ectopic expression of either mir-34a or mir-34b/c in IMR90 cells led to substantial inhibition of growth (Fig. 3a) . This was attributable to effects on cell proliferation: the fraction of S-phase cells decreased, and the fraction of cells in G1 and G2 increased (Fig. 3b) . We also noted distinctive morphological alterations characteristic of cellular senescence (Fig. 3c) , and about 60% of infected cells stained positively for a senescence marker, SA-b-Gal, at 6 days after selection (Fig. 3d) . Importantly, all of these effects were seen with mir-34 expression levels similar to those achieved after p53-mediated induction ( Supplementary Fig. S5 ). Transfection of miR-34 miRNAs, but not that of miR-34s containing seed mutations, also led to G1 arrest in immortalized mouse cells and in human tumour cell lines including NIH-3T3, HCT-116, A549 and TOV21G ( Supplementary Fig. S6 , data not shown). These studies indicate that arrest can be induced independently of the integrity of major tumour suppressor pathways, at least in some cell lines (Fig. 3, and data not shown) . Ectopic delivery of miR-34a also sensitized MEFs to apoptosis in response to genotoxic stress, although the effects were not as pronounced as the growth arrest induced by this miRNA (data not shown).
miRNAs often decrease the mRNA levels of direct regulatory targets 15 . After transfection of miR-34a, b or c into a panel of four tumour cell lines, a cluster of genes was specifically downregulated at 24 h after transfection ( Supplementary Fig. S7 and Supplementary  Table S2) , with some genes showing significant repression as early as 10 h after transfection. These genes were highly enriched for transcripts with 39 untranslated regions (UTRs) containing complements to miR-34 seed hexamers. On the basis of functional annotation, genes involved in control of the cell cycle were strongly overrepresented among this set (P , 3.4 3 10
220
; Supplementary Fig. S7 ). A selection of candidate targets, including cyclin E2 (CCNE2), cyclindependent kinase 4 (CDK4) and the hepatocyte growth factor receptor (MET) 16 , were validated by western blotting (Fig. 4a , and Supplementary Fig. S8 ). On transfection of miR-34a into A549 and HCT116 cells, we observed the expected twofold to fourfold decrease in each target examined 15 . To test whether regulation was direct, we fused the 39 UTRs of these selected targets to luciferase. Co-transfection with miR-34a but not miR-124a specifically decreased luciferase levels from each reporter (Fig. 4b) . Mutations in seed complementary sites fully rescued repression for both CDK4 and MET. For cyclin E2, mutation of the single best seed complementary site had only a partial effect (Fig. 4b) , indicating either the presence of other relevant seed complements or a combination of both direct and indirect effects of miR-34. Silencing of these selected miR-34 targets by using siRNAs led to a substantial arrest in G1 (Fig. 4c) , partly phenocopying activation of their upstream regulator. Ectopic miR-34 delivery caused a decrease in levels of phosphorylated retinoblastoma gene product (Rb), consistent with lowered activity of both CDK4 and CCNE2 complexes (Fig. 4a) . Repression of CDK4 and CCNE2 has previously been noted after p53 activation in PC3 cells 7 . Our results indicate the possibility that p53 might repress these genes indirectly by the induction of miR-34.
We also noted a significant overlap between miR-34-regulated genes and those whose expression is altered after DNA damage ( Supplementary Fig. S7 ). This was seen both for genes that increased after either miR-34 delivery or DNA damage (P , 7 3 10
265
) and for those that decreased in response to either treatment (P , 1.8 3 10 273 ). Although strong seed enrichment was seen in the mutually downregulated set, seed enrichment was not seen in the mutually upregulated set, indicating that such increases in expression might be secondary effects of miR-34.
Activation of p53 leads to the coordinated induction of multiple downstream effectors, many of which act in a partly or fully redundant manner. A classic example is p53-dependent apoptosis, which depends not only on the induction of bax 17 but also on puma and noxa 18 . For p53-mediated growth arrest, induction of the CDK inhibitor p21 is clearly important. However, p21 loss does not completely negate the ability of p53 to halt proliferation 19, 20 . This demonstrates the existence of redundant or cooperating pathways that contribute to p53-mediated arrest in G1. Recent studies have identified several p53 targets, including Gadd45a (for growth arrest and DNAdamage-inducible), 14-3-3 and Reprimo, which have been proposed to collaborate with p21, primarily to trigger arrest in G2 in specific cell types 3 . At least in some contexts, miR-34s can exert their growth inhibitory effects in the absence of p21, because HCT-116 cells lacking p21 are susceptible to miR-34 ( Supplementary Fig. S6B ). This is especially important because reports have implicated p21 in p53-mediated repression 21 . Our data identify the miR-34 family of miRNAs as direct targets of p53 that possess anti-proliferative potential. It is likely that miR34s mediate this response through additive or synergistic effects of multiple targets, because many components of the cell cycle machinery are affected after the manipulation of miR-34 levels. The effects of miR-34s may also extend to the other arm of the p53 response, given a recent report and our findings (data not shown) that miR-34a can enhance apoptotic responses in some cell types 22 . Thus, the actual phenotypic output of miR-34 activation may vary by cell type depending on the spectrum of its targets that are available for repression.
In accord with their regulation by p53, comparatively low levels of miR-34s are observed in human tumours and cancer cell lines, which have a high frequency of functional p53 deficiency. Although selective pressures for miR-34 deletion in human cancers may be alleviated by frequent p53 mutations, deletion of miRNAs of the miR-34 family has been reported in several human tumours and cancer cell lines 22, 23 . In fact, the human gene encoding miR-34a maps to 1p36, a locus frequently deleted in human cancers. Recently, one gene within this locus, CHD5, has been implicated in its tumour suppressive activity 24 . CHD5 has been proposed to act upstream of p53 by regulating its expression in response to various p53-inducing stimuli. Deletions at 1p36 are often quite large and can encompass both CHD5 and the mir-34a locus, as well as other genes. Thus, 1p36 genomic lesions might affect the p53 pathway at multiple levels, both upstream and downstream of p53 activation.
Although dozens of p53 targets have been identified in mammals, very few are evolutionarily conserved in Drosophila and Caenorhabditis elegans, both of which retain homologues of the p53 pathway 25 . miR-34 is one of only 18 mammalian miRNA families 26 that are also present in flies and worms. This raises the . c, HCT116 Dicer ex5 cells were transfected with siRNAs targeting CDK4, CCNE2 and MET, and cell cycle effects were analysed as described in Supplementary Fig. S6 . The somewhat less efficacious arrest on transfection with CCNE2 siRNA could reflect a partly redundant function or less potent suppression of its mRNA.
possibility that the link between p53 and this non-coding RNA target may have arisen early in the evolution of the p53 network and may be important in p53 function in diverse species.
METHODS SUMMARY
miRNA expression analyses. TaqMan MicroRNA assays were used to quantify levels of mature miRNAs as described previously 9 . Primary miR-34 transcript levels were determined with the SuperScript III SYBR Green One-Step qRT-PCR system (Invitrogen). Proliferation and cell cycle analysis. Primary IMR90 cells were infected with murine stem cell virus (MSCV) retroviral vectors expressing mir-34a or mir-34b/ c and were used for a variety of growth assays. Cell cycle distributions were measured with the bromodeoxyuridine (BrdU) APC flow kit (BD Biosciences). Tumour-derived cell lines, including A549 and HCT116, were transiently transfected with luciferase siRNA GL-3 or miR-34a-c duplexes (100 nM). After 24 h, transfected populations were treated for 16-20 h with nocodazole (100 ng ml 21 ). Cell cycle profiles were determined by staining with propidium iodide, followed by fluorescence-activated cell sorting (FACS). ChIP and promoter reporter assays. For reporter assays, putative promoter regions of human mir-34a and mir-34b/c were amplified from genomic DNA and cloned upstream of firefly luciferase in the pGL4 plasmid (Promega). Mutagenesis of p53 binding sites was performed with the QuickchangeXL mutagenesis kit (Strategene). pGL4 vectors containing wild-type and mutant mir-34 promoters were transfected into the HCT116 p53 2/2 cells, together with either the pLPC-p53 vector or an empty vector. The promoter activity of each construct was determined by dual luciferase assay (Promega) 24 h after transfection. Microarray profiling and western analysis. miRNA duplexes (100 nM) were transfected into all cell lines. RNA was isolated 6-24 h after transfection, and microarray analysis was performed as described 15 . Antibodies against CDK4 (Santa Cruz), CCNE2, MET (Cell Signaling) and phospho-Rb (Santa Cruz) were used in western analysis in accordance with the manufacturer's instructions. Anti-tubulin antibodies (Sigma) were used to test for equal loading.
Full Methods and any associated references are available in the online version of the paper at www.nature.com/nature.
